These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 9780788)

  • 1. Efficacy of alpha 2b versus lymphoblastoid interferon in treatment of chronic hepatitis C. A randomized trial.
    González Sánchez M; Palacios A; Caballero T; Torres Fernández-Piñar C; Bellot V; Ruiz Extremera A; Salmerón J
    Rev Esp Enferm Dig; 1998 Aug; 90(8):553-62. PubMed ID: 9780788
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC; Bacon BR; Goldin RD
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alpha-2b in the treatment of chronic hepatitis C: early experience.
    Ching NP; Lumeng J; Pang R; Pang G; Or FW; Ching NW; Ching C
    Hawaii Med J; 1998 Dec; 57(12):735-9. PubMed ID: 9893388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different types of interferon for the therapy of HCV chronic active hepatitis in the elderly patient.
    Terranova R; Luca S
    Eur Rev Med Pharmacol Sci; 1999; 3(2):45-52. PubMed ID: 10827804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alfa for chronic hepatitis C infection.
    Kingsley D
    Lancet; 1999 Feb; 353(9151):499; author reply 500. PubMed ID: 9989746
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of combined interferon and ribavirin for treatment of hepatitis C.
    Brown JL
    Lancet; 1998 Jan; 351(9096):78-9. PubMed ID: 9439486
    [No Abstract]   [Full Text] [Related]  

  • 7. r-Interferon alfa-2b/ribavirin combined therapy followed by low-dose r-interferon alfa-2b in chronic hepatitis C interferon nonresponders.
    Perasso A; Testino G; Ansaldi F; Venturino V; Icardi GC
    Hepatology; 1999 Jan; 29(1):297-8. PubMed ID: 9935339
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatment.
    Valla DC; Chevallier M; Marcellin P; Payen JL; Trepo C; Fonck M; Bourliere M; Boucher E; Miguet JP; Parlier D; Lemonnier C; Opolon P
    Hepatology; 1999 Jun; 29(6):1870-5. PubMed ID: 10347132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon alfa for chronic hepatitis C infection.
    Delgado Fernández M; Zambrana García JL; Díez García F
    Lancet; 1999 Feb; 353(9151):499-500. PubMed ID: 9989747
    [No Abstract]   [Full Text] [Related]  

  • 10. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
    Payen JL; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski JP; Seigneurin JM; Dussaix E; Voigt JJ; Selves J; Barange K; Puel J; Pascal JP
    Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C therapy: is it really worth it?
    Johanson JF
    Am J Gastroenterol; 1999 May; 94(5):1412-3. PubMed ID: 10235231
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of interferon treatment for patients with chronic hepatitis C: comparison of response in cirrhotics, fibrotics, or nonfibrotics.
    Everson GT; Jensen DM; Craig JR; van Leeuwen DJ; Bain VG; Ehrinpreis MN; Albert D; Joh T; Witt K
    Hepatology; 1999 Jul; 30(1):271-6. PubMed ID: 10385666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon in wonderland.
    Koretz RL
    Gastroenterology; 1998 Oct; 115(4):1027-9. PubMed ID: 9786731
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients.
    el-Zayadi A; Selim O; Haddad S; Simmonds P; Hamdy H; Badran HM; Shawky S
    Ital J Gastroenterol Hepatol; 1999; 31(6):472-5. PubMed ID: 10575565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon treatment of children with chronic hepatitis C.
    al-Tawil Y; Nelson C
    Hepatogastroenterology; 1998; 45(20):345-8. PubMed ID: 9638404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
    Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
    Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic hepatitis C genotype 4 with alpha-interferon in Saudi Arabia: a multicenter study.
    al-Faleh FZ; Sbeih F; al-Karawi M; al-Mofleh IA; al-Rashed RS; Ayoola A; al-Amri S; Mayet I; al-Habbal TM; al-Omair A; al-Sohaibani MO; Abdullah AO; Mohamed SA; el-Sheikh MA
    Hepatogastroenterology; 1998; 45(20):488-91. PubMed ID: 9638433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic hepatitis C: interferon alpha-2b alone or in combination with ribavirin].
    Fontaine H; Pol S
    Gastroenterol Clin Biol; 1999 Apr; 23(4):541-4. PubMed ID: 10416124
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study.
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Rizzo G; Barbarini G
    Am J Gastroenterol; 1998 Dec; 93(12):2445-51. PubMed ID: 9860407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
    McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
    N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.